| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/25/2003 | US20030236281 Quinoline derivatives(2) |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236279 Central nervous system disorders; psychological disorders |
| 12/25/2003 | US20030236274 Naphthalene derivatives, their production and use |
| 12/25/2003 | US20030236273 Aryl substituted pyrimidines and the use thereof |
| 12/25/2003 | US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 12/25/2003 | US20030236270 Central nervous system disorders |
| 12/25/2003 | US20030236267 Benzimidazole derivatives |
| 12/25/2003 | US20030236263 Chemical compounds |
| 12/25/2003 | US20030236262 Dietetics; antidiabetic agents; sexual disorders |
| 12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/25/2003 | US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease |
| 12/25/2003 | US20030236251 Hepatitis virus viricides |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236249 Prevent binding to chemokines |
| 12/25/2003 | US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction |
| 12/25/2003 | US20030236240 Macrocycles useful in the treatment of alzheimer's disease |
| 12/25/2003 | US20030236232 Novel spla2 inhibitors |
| 12/25/2003 | US20030236222 For the prevention and/or treatment of motoneuron diseases |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer |
| 12/25/2003 | US20030236202 Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 12/25/2003 | US20030236197 Modulators of beta-amyloid peptide aggregation |
| 12/25/2003 | US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine |
| 12/25/2003 | US20030235916 Cationic with cationic surfactant |
| 12/25/2003 | US20030235900 Anticancer agents |
| 12/25/2003 | US20030235888 Therapy for bone defects |
| 12/25/2003 | US20030235631 Administering mixtures of phosphodiesterase inhibitors, anxiolytic agents and antidepressants for prophylaxis of psycholical disorders; efficiency |
| 12/25/2003 | US20030235628 Mixtures of proton pump inhibitor such as lansoprazole and water soluble and insoluble bases, used for prophylaxis of gastrointestinal disorders; neutralization gastric juices |
| 12/25/2003 | US20030235611 Vesicle comprises ATP and phospholipid; fusion proteins |
| 12/25/2003 | US20030235609 Use of cholinesterase antagonists to treat insulin resistance |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/25/2003 | US20030235582 Anti-IGF-I receptor antibody |
| 12/25/2003 | US20030235556 Combination IL-2/anti-HER2 antibody therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 12/25/2003 | US20030235536 Administering an aerosol, a conjugate of a therapeutic agent and an FcRn binding partner, for treating resipiratory system disorders, drug delivery of an antibody, immunizing vaccines |
| 12/25/2003 | US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
| 12/24/2003 | WO2003107006A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | WO2003106974A2 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | WO2003106970A2 P27 prevents cellular migration |
| 12/24/2003 | WO2003106683A1 Novel screening method |
| 12/24/2003 | WO2003106669A1 Purified pkb ser 473 kinase and uses thereof |
| 12/24/2003 | WO2003106659A2 Aptamer-toxin molecules and methods for using same |
| 12/24/2003 | WO2003106636A2 Novel methods for the delivery of polynucleotides to cells |
| 12/24/2003 | WO2003106621A2 Anti-igf-i receptor antibody |
| 12/24/2003 | WO2003106506A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 12/24/2003 | WO2003106473A1 1-carboxymethyl analogues of glucosyl lipid a |
| 12/24/2003 | WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | WO2003106459A1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 12/24/2003 | WO2003106456A2 New compounds |
| 12/24/2003 | WO2003106452A2 Antagonists of melanin concentrating hormone receptor |
| 12/24/2003 | WO2003106449A1 Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments |
| 12/24/2003 | WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | WO2003106441A1 Pharmaceutical salts of reboxetine |
| 12/24/2003 | WO2003106429A1 Prodrug and process for producing the same |
| 12/24/2003 | WO2003106426A1 Compounds, compositions, and methods |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106423A1 Cyclic amine and medicinal composition containing the same |
| 12/24/2003 | WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 12/24/2003 | WO2003106418A1 Indole, indazole, and benzazole derivative |
| 12/24/2003 | WO2003106417A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003106411A1 24-sulfoximine vitamin d3 compounds |
| 12/24/2003 | WO2003106402A1 2-naphtamide derivatives |
| 12/24/2003 | WO2003106385A2 Process for screening fungitoxic compounds |
| 12/24/2003 | WO2003106381A2 Human adam-10 inhibitors |
| 12/24/2003 | WO2003106380A2 Fluorobenzamides |
| 12/24/2003 | WO2003105902A1 Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent |
| 12/24/2003 | WO2003105901A2 New medical indication |
| 12/24/2003 | WO2003105893A2 Probiotic therapies |
| 12/24/2003 | WO2003105880A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/24/2003 | WO2003105878A1 Antibacterial agent and antibacterial composition |
| 12/24/2003 | WO2003105857A1 Anti-inflammatory compositions and methods of use |
| 12/24/2003 | WO2003105855A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003105848A1 Controlled-release drug composition |
| 12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105845A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 12/24/2003 | WO2003105844A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions |
| 12/24/2003 | WO2003105838A2 Metabolite |
| 12/24/2003 | WO2003105830A1 Medicinal compositions improving brain function and method for improving brain function |
| 12/24/2003 | WO2003105823A1 Use of hydroxyeicosatetraenoic acid compounds to treat dry mouth |
| 12/24/2003 | WO2003105819A1 Quinone-type remedy for liver disease |
| 12/24/2003 | WO2003105818A1 Quinone-based remedies for liver diseases |
| 12/24/2003 | WO2003105815A1 Combination of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 12/24/2003 | WO2003105779A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105770A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/24/2003 | WO2003105666A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | WO2003091274A3 Use of alpha-s2 casein precursor-derived peptided |
| 12/24/2003 | WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2003 | WO2003089593A3 Adjuvant enhanced immunotherapy |
| 12/24/2003 | WO2003089007B1 Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| 12/24/2003 | WO2003087298A3 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases |
| 12/24/2003 | WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 12/24/2003 | WO2003086102A3 Method for the production of potato juice products by means of food technology |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |